Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Recruiting now

Conditions studied: Open Angle Glaucoma (OAG), Ocular Hypertension (OH)

In brief

Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)

Key facts

Study ID

NCT07400926

Run by

Glaukos Corporation

People needed

30

Starts

2025-12-17

Expected to finish

2026-07-01

Last updated by the study team

2026-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Open-angle glaucoma
• 18 years of age or older

You may not qualify if…

• Subject who is breast-feeding or pregnant

Where it is running

• Glaukos Investigative Site — Kenosha, Wisconsin, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.